Securities code: Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) Announcement No.: 2022021
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) board of supervisors
About the granting of the company’s restricted stock incentive plan in 2022
Verification opinions on relevant matters
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) (hereinafter referred to as “the company”) the board of supervisors in accordance with the company law, the securities law, the measures for the administration of equity incentive of listed companies (hereinafter referred to as “the measures”) and other relevant laws, regulations, normative documents and the articles of association, Review the list of incentive objects of the company’s 2022 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) and give the following verification opinions: 1. Except that some personnel leave their jobs for personal reasons and are disqualified from participating in the company’s 2022 restricted stock incentive plan, The incentive objects granted with restricted shares this time are consistent with the incentive objects specified in the company’s 2022 restricted stock incentive plan (Draft) approved by the company’s first extraordinary general meeting in 2022. 2. The incentive object does not have the situation that it is not allowed to become the incentive object as stipulated in the management measures:
(1) Being identified as an inappropriate candidate by the stock exchange within the last 12 months;
(2) In the last 12 months, it has been identified as an inappropriate candidate by the CSRC and its dispatched offices;
(3) Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations in the last 12 months;
(4) Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law;
(5) Those who are not allowed to participate in the equity incentive of listed companies according to laws and regulations;
(6) Other circumstances recognized by the CSRC.
3. The incentive objects are middle-level managers, core technology and business backbone employees in the company, excluding independent directors, supervisors, shareholders or actual controllers who individually or jointly hold more than 5% of the company’s shares and their spouses, parents and children.
4. All incentive objects have the qualifications specified in the company law, securities law, articles of association and other laws, regulations and normative documents, and meet the conditions of incentive objects specified in the management measures and other documents
Securities code: Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) Announcement No.: 2022021
In line with the scope of incentive objects specified in the incentive plan, its qualification as the incentive object of the company’s restricted shares is legal and effective.
5. The granting date determined by the board of directors complies with the provisions of the administrative measures and the incentive plan on the granting date. Neither the company nor the incentive objects granted this time are allowed to grant restricted shares, and the conditions set by the company’s incentive plan for the incentive objects to be granted restricted shares have been met.
In conclusion, the board of supervisors agreed that the granting date of the company’s restricted stock incentive plan in 2022 was March 1, 2022, and 5780000 restricted shares were granted to 77 incentive objects.
It is hereby announced.
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) board of supervisors March 1, 2002
